150 related articles for article (PubMed ID: 18616796)
1. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study.
Lummis HL; Sketris IS; Gubitz GJ; Joffres MR; Flowerdew GJ
BMC Neurol; 2008 Jul; 8():25. PubMed ID: 18616796
[TBL] [Abstract][Full Text] [Related]
2. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users.
Adams AS; Uratsu C; Dyer W; Magid D; O'Connor P; Beck A; Butler M; Ho PM; Schmittdiel JA
JAMA Intern Med; 2013 Jan; 173(1):54-61. PubMed ID: 23229831
[TBL] [Abstract][Full Text] [Related]
3. Disparities in Antihypertensive Prescribing After Stroke: Linked Data From the Australian Stroke Clinical Registry.
Dalli LL; Kim J; Thrift AG; Andrew NE; Lannin NA; Anderson CS; Grimley R; Katzenellenbogen JM; Boyd J; Lindley RI; Pollack M; Jude M; Durairaj R; Shah D; Cadilhac DA; Kilkenny MF
Stroke; 2019 Dec; 50(12):3592-3599. PubMed ID: 31648630
[TBL] [Abstract][Full Text] [Related]
4. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
5. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
Burke JP; Sander S; Shah H; Zarotsky V; Henk H
Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138
[TBL] [Abstract][Full Text] [Related]
6. Initial persistence with antihypertensive therapies is associated with depression treatment persistence, but not depression.
Schmittdiel JA; Dyer W; Uratsu C; Magid DJ; O'Connor PJ; Beck A; Butler M; Ho MP; Vazquez-Benitez G; Adams AS
J Clin Hypertens (Greenwich); 2014 Jun; 16(6):412-7. PubMed ID: 24716533
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with early nonpersistence among patients experiencing side effects from a new medication.
Alefan Q; Yao S; Taylor JG; Lix LM; Eurich D; Choudhry N; Blackburn DF
J Am Pharm Assoc (2003); 2022; 62(3):717-726.e5. PubMed ID: 34980560
[TBL] [Abstract][Full Text] [Related]
8. Understanding of medications and associations with adherence, unmet needs, and perceived control of risk factors at two years post-stroke.
Dalli LL; Andrew NE; Kim J; Cadilhac DA; Sanfilippo FM; Thrift AG; Nelson MR; Lannin NA; Olaiya MT; Ryan OF; Booth B; Gall S; Kilkenny MF;
Res Social Adm Pharm; 2022 Sep; 18(9):3542-3549. PubMed ID: 35093283
[TBL] [Abstract][Full Text] [Related]
9. Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
JAMA Cardiol; 2020 May; 5(5):532-539. PubMed ID: 32129795
[TBL] [Abstract][Full Text] [Related]
10. Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication.
Tamblyn R; Abrahamowicz M; Dauphinee D; Wenghofer E; Jacques A; Klass D; Smee S; Eguale T; Winslade N; Girard N; Bartman I; Buckeridge DL; Hanley JA
Arch Intern Med; 2010 Jun; 170(12):1064-72. PubMed ID: 20585073
[TBL] [Abstract][Full Text] [Related]
11. Compliance with secondary prevention of ischemic stroke: a prospective evaluation.
Sappok T; Faulstich A; Stuckert E; Kruck H; Marx P; Koennecke HC
Stroke; 2001 Aug; 32(8):1884-9. PubMed ID: 11486121
[TBL] [Abstract][Full Text] [Related]
12. Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke.
Thrift AG; Kim J; Douzmanian V; Gall SL; Arabshahi S; Loh M; Evans RG
Stroke; 2014 Feb; 45(2):539-44. PubMed ID: 24335222
[TBL] [Abstract][Full Text] [Related]
13. A prescription at discharge improves long-term adherence for secondary stroke prevention.
Tsai JP; Rochon PA; Raptis S; Bronskill SE; Bell CM; Saposnik G
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2308-15. PubMed ID: 25149205
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in persistence to secondary prevention medication regimens after ischemic stroke.
Sheehan OC; Dhamoon MS; Bettger JP; Huang J; Liu C; Rhodes JD; Clay OJ; Roth DL
Ethn Health; 2022 Oct; 27(7):1671-1683. PubMed ID: 34196573
[TBL] [Abstract][Full Text] [Related]
15. Persistence with stroke prevention medications 3 months after hospitalization.
Bushnell CD; Zimmer LO; Pan W; Olson DM; Zhao X; Meteleva T; Schwamm L; Ovbiagele B; Williams L; Labresh KA; Peterson ED;
Arch Neurol; 2010 Dec; 67(12):1456-63. PubMed ID: 20697032
[TBL] [Abstract][Full Text] [Related]
16. Prescription of antihypertensive medication at discharge influences survival following stroke.
Andrew NE; Kim J; Thrift AG; Kilkenny MF; Lannin NA; Anderson CS; Donnan GA; Hill K; Middleton S; Levi C; Faux S; Grimley R; Gange N; Geraghty R; Ermel S; Cadilhac DA;
Neurology; 2018 Feb; 90(9):e745-e753. PubMed ID: 29386279
[TBL] [Abstract][Full Text] [Related]
17. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
[TBL] [Abstract][Full Text] [Related]
18. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
[TBL] [Abstract][Full Text] [Related]
19. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany.
Breitscheidel L; Ehlken B; Kostev K; Oberdiek MS; Sandberg A; Schmieder RE
J Med Econ; 2012; 15(1):155-65. PubMed ID: 22035215
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic and antihypertensive management 3 months after ischemic stroke : a prospective study in an inner city population.
Hillen T; Dundas R; Lawrence E; Stewart JA; Rudd AG; Wolfe CD
Stroke; 2000 Feb; 31(2):469-75. PubMed ID: 10657424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
